{"sections":[{"heading":"Interactomics and the O-1A evidence challenge","paragraphs":["Interactomics is the systematic study of protein-protein interactions at a genomic scale, aiming to map complete interactomes for model organisms and human disease pathways. The field operates at the intersection of structural biology, mass spectrometry, and computational network analysis, and its primary institutional home is the NIH National Institute of General Medical Sciences (NIGMS) and the NSF Division of Molecular and Cellular Biosciences (MCB). Core journals include Nature Methods, Molecular Cell, Nature Structural and Molecular Biology, and Molecular Systems Biology. Major annual meetings include the Cold Spring Harbor meetings on Protein Networks and Systems Biology and the American Society for Biochemistry and Molecular Biology (ASBMB) annual meeting.","The O-1A challenge for interactomics researchers begins with field definition. Because the field is inherently interdisciplinary — drawing methodology from proteomics, bioinformatics, and cell biology — a petitioner may publish across multiple parent disciplines and hold memberships in several scientific societies. The petition must anchor the extraordinary ability claim to a defined peer community: the researchers who evaluate NIGMS study section applications, publish in Nature Methods on proximity labeling workflows, and contribute to the interactome databases — BioGRID, IntAct, STRING — that serve as shared community infrastructure.","A second structural challenge involves individual attribution within large-team projects. A comprehensive interactome mapping study typically involves multiple co-investigators contributing AP-MS workflows, computational analysis pipelines, and validation assays. The petition brief must clearly delineate the petitioner's specific intellectual contributions — whether defining the experimental architecture, developing novel interaction detection chemistry, or producing the computational methods that interpret network-level biology — rather than relying on co-authorship alone as evidence of contribution. USCIS adjudicators are trained to ask whether a petitioner played a leading role or a supporting one, and the brief must answer that question before an RFE asks it."]},{"heading":"Scholarly articles and high-impact publications","paragraphs":["Publications in Nature Methods carry distinctive weight for interactomics researchers because that journal serves as the venue of record for methodological innovations in protein interaction detection. A first-author or co-corresponding author article describing a new proximity labeling enzyme variant, an improved AP-MS sample preparation workflow, or a novel computational method for distinguishing specific from non-specific interactions documents both the scholarly articles criterion and the original contributions criterion simultaneously. The petition should include full citation data for each article, with field-specific context explaining why a given citation count signals wide adoption of the method rather than narrow specialist interest.","Molecular Cell and Cell Systems are appropriate venues for papers reporting biologically significant interactomes — for example, a comprehensive interaction network for a disease-relevant protein complex or a comparative interactome study across cell types or conditions. PLOS Computational Biology is the standard venue for computational interactomics papers that develop new network analysis algorithms. The petition should present these publications on a trajectory, showing that the petitioner has advanced from first-author methodology papers to co-corresponding-author biological papers, which signals growing leadership in defining research questions rather than merely executing experiments.","For preprints, the petition should note that BioRxiv preprints are structurally common in interactomics because of the field's fast pace, but only peer-reviewed publications should be submitted as primary evidence under the scholarly articles criterion. Where a preprint was widely cited and then published, the petition can document both timelines to show the field's engagement with the work throughout the peer review period. For RECOMB and ISMB conference papers, the brief should explain those venues' acceptance rates and review rigor, since USCIS has not historically treated them as equivalent to peer-reviewed journal articles without supporting context."]},{"heading":"Peer review and judging service","paragraphs":["NIH study section service is the most credible form of judging evidence for interactomics researchers because it is documented by a federal agency and involves formal selection of reviewers based on field expertise. The Scientific Review Officer for a given study section can provide a letter confirming the reviewer's participation, the study sections served, and the number of review meetings attended. Study sections most relevant to interactomics include the Biochemistry and Biophysics of Membranes panel, the Molecular Structure and Function panels, and the Biodata Management and Analysis panel for computational interactomics researchers.","Ad hoc peer review for Nature Methods, Molecular Cell, and PLOS Computational Biology supplements formal study section service. The petition should document total review volume and the journals reviewed for, supported by editor confirmation letters where available. USCIS has occasionally questioned whether ad hoc review constitutes judging under 8 C.F.R. § 214.2(o)(3)(iv)(D) because ad hoc reviewers lack formal appointment. The petition brief should address this proactively by explaining that Nature Methods invites reviewers based on their expertise and standing in the field — the invitation is itself evidence of peer recognition — and that the volume of invitations correlates with stature within the interactomics community.","NSF review panel service for the Division of Molecular and Cellular Biosciences, and service on grant review panels for international funding agencies such as the European Research Council or the Wellcome Trust, provides additional judging documentation. Where a researcher has served on multiple panels across multiple agencies over multiple years, the petition can present this record cumulatively as evidence of sustained recognition as a scientific evaluator — a framing that goes beyond documenting the judging criterion alone and contributes to the overall extraordinary ability narrative."]},{"heading":"Original contributions to protein interaction networks","paragraphs":["The original contributions criterion at 8 C.F.R. § 214.2(o)(3)(iv)(C) requires evidence of original contributions of major significance. For interactomics researchers, the strongest evidence comes from methodological innovations subsequently adopted independently by other laboratories. If a researcher developed a proximity labeling enzyme variant — a BioID derivative, a TurboID modification, or a split-enzyme system — and other groups adopted it in their own interactome mapping projects, that adoption record documented through citations to the methods paper and independent publications using the method demonstrates major significance. Commercial availability of a reagent derived from the innovation further confirms that the contribution has moved from research output to community infrastructure.","Large-scale interactome datasets deposited in BioGRID, IntAct, or a field-specific database provide a distinctive form of original contribution evidence. If a researcher's published interactome is the standard reference dataset for a particular organism, tissue, or disease pathway — documented through citation counts, downstream database integration, and use as a background network in independent computational studies — the petition can frame this as infrastructure contribution. Expert declarations from researchers who built on the dataset should describe specifically which scientific questions the dataset enabled them to address and why the petitioner's version of the interactome was methodologically superior to alternatives.","For computational contributions, the petition should document whether algorithms or software packages developed by the petitioner are in widespread use. GitHub download statistics, citations to the software publication, integration into commonly used pipelines such as Cytoscape or STRING-based workflows, and adoption in clinical proteomics pipelines all document that a computational interactomics contribution has achieved major significance beyond the petitioner's own publications. Where software usage metrics are available from PyPI or Bioconductor download statistics, these should be included with field-specific context explaining what usage volume is typical for research-grade bioinformatics tools."]},{"heading":"NIH and NSF grant records as peer recognition","paragraphs":["NIH and NSF grant records serve double duty in an interactomics O-1A petition. They function as a form of peer recognition evidence — because grant selection involves external scientific review, a funded grant documents that a qualified peer panel evaluated the petitioner's proposed research program and found it meritorious enough to fund — and they can also establish critical role evidence when the petitioner is a principal investigator on a significant multi-investigator project. The most petition-relevant grants are NIH R01 and R35 awards through NIGMS MIRA, NIH Director's New Innovator Award (DP2), and NSF CAREER awards, all of which involve competitive peer evaluation.","When presenting grants as peer recognition evidence, the petition should include the notice of award, any available summary statements from the review process which document reviewer scores and percentiles, and a brief narrative explaining the review process. USCIS adjudicators are not generally familiar with the NIH percentile scoring system — a 6th-percentile score is not intuitively meaningful without an explanation that NIH typically funds applications below the 10th percentile and that approximately 20 percent of reviewed applications receive funding in any given cycle. Providing this context converts a grant document into compelling recognition evidence.","International fellowship or grant records from European agencies such as the European Research Council, Wellcome Trust, or EMBO, or from national science foundations in the petitioner's home country, carry weight if they can be analogized to NIH or NSF in terms of competitive selection and peer review rigor. The petition brief should explain the selection process for any non-U.S. grant, the number of competing applications, and the selection rate, since USCIS adjudicators have no baseline familiarity with foreign funding agency structures. A funding record spanning multiple competitive agencies demonstrates sustained external validation of the petitioner's research program."]},{"heading":"High salary and building a complete petition","paragraphs":["The high salary criterion for academic interactomics researchers uses BLS Occupational Employment and Wage Statistics for Biochemists and Biophysicists (SOC code 19-1021). Salaries above the 90th percentile nationally, or above the 75th percentile in research-intensive markets such as San Francisco, Boston, or New York, support the criterion. Academic researcher positions at major research universities — assistant professor, associate professor, and research scientist titles at institutions with active NIH R01 portfolios — typically carry salaries within or above the BLS benchmark ranges for this occupational category, particularly when salary supplements from grants and core facilities are included. The petition should include offer letters, W-2 or IRS Form 1042-S records, and the relevant OEWS tables.","For industry-employed interactomics researchers at pharmaceutical companies, biotechnology firms, or proteomics core facilities, compensation benchmarks from Levels.fyi or BioSpace for senior research scientist and principal scientist roles provide useful supplementary data. Equity components — RSUs, stock options, and sign-on grants — should be included in the total compensation exhibit when their value is documentable from grant agreements or company-issued compensation letters. The petition brief should explain the standard compensation structure at the employing company and how the petitioner's package compares to the range for comparable roles.","A complete O-1A petition for an interactomics researcher typically leads with scholarly articles and original contributions as the anchor criteria, supplemented by judging through NIH study section service, grant records as peer recognition, and membership where HHMI or Academy affiliation is available. The petition brief must preemptively define the field, attribute individual contributions within collaborative projects, and explain the significance of methodological innovations in non-specialist terms. An expert declaration from a senior researcher in protein interaction biology — someone with an established interactomics publication record and the standing to evaluate the petitioner's contribution to the field — is essential for tying the criteria together into a coherent extraordinary ability argument."]}],"article":{"title":"O-1A for Interactomics Researchers: NIH and NSF Grant Records, Nature Methods Publications, and Protein Interaction Network Contributions","excerpt":"Interactomics researchers map protein interaction networks across entire genomes — and translating that collaborative, computational work into O-1A evidence requires careful individual attribution and field definition. This guide covers NIH study section records, Nature Methods publications, NIGMS grant documentation, and how to build an O-1A petition that USCIS can evaluate.","category":"O-1A Guide","date":"Oct 6, 2026","readTime":"8 min read"},"prev":{"title":"O-1A for Junior Faculty Before Tenure: Building an Extraordinary Ability Petition on Publications, Grant Records, and Pre-Tenure Recognition","slug":"o-1a-for-junior-faculty-before-tenure-building-an-extraordinary-ability-petition-on-publications-grant-records-and-pre-tenure-recognition"},"next":{"title":"O-1A for Exobiologists: NASA Astrobiology Institute Grant Records, Astrobiology Journal Publications, and Field Recognition Evidence","slug":"o-1a-for-exobiologists-nasa-astrobiology-institute-grant-records-astrobiology-journal-publications-and-field-recognition-evidence"},"related":[{"title":"O-1A for Computational Fluid Dynamics Researchers in Industry: Patent Records, AIAA Publications, and Critical Role Evidence","slug":"o-1a-for-computational-fluid-dynamics-researchers-in-industry-patent-records-aiaa-publications-and-critical-role-evidence"},{"title":"O-1A for Remote Sensing and Earth Observation Researchers: NASA and ESA Grant Records, ISPRS Publications, and O-1A Evidence","slug":"o-1a-for-remote-sensing-and-earth-observation-researchers-nasa-and-esa-grant-records-isprs-publications-and-o-1a-evidence"},{"title":"O-1A for Metallurgical Engineers: TMS Awards and Publications","slug":"o-1a-for-metallurgical-engineers-tms-awards-and-publications"},{"title":"O-1A for Exobiologists: NASA Astrobiology Institute Grant Records, Astrobiology Journal Publications, and Field Recognition Evidence","slug":"o-1a-for-exobiologists-nasa-astrobiology-institute-grant-records-astrobiology-journal-publications-and-field-recognition-evidence"},{"title":"O-1A for Brain-Computer Interface Researchers: NIH BRAIN Initiative Records, IEEE TNSRE Publications, and O-1A Evidence","slug":"o-1a-for-brain-computer-interface-researchers-nih-brain-initiative-records-ieee-tnsre-publications-and-o-1a-evidence"},{"title":"O-1A for Neuroprosthetics Researchers: NIH BRAIN Initiative Grant Records, Journal of Neural Engineering Publications, and O-1A Evidence","slug":"o-1a-for-neuroprosthetics-researchers-nih-brain-initiative-grant-records-journal-of-neural-engineering-publications-and-o-1a-evidence"}]}